Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening

Abstract

Cervical cancer screening; Clinical sensitivity; Clinical specificity; Human papillomavirus (HPV); Real-time PCR